Stimulating knowledge, research, and impactful interactions related to Translational Digital Biomarkers (TBD) in North America and beyond.
Connecting technology providers, industry, academics, and regulatory stakeholders to increase adoption of TBD technologies.
Trans Dig Biom medium

The Translational Digital Biomarkers Initiative will connect early stage and commercially available digital biomarker providers, industry, academics and regulatory stakeholders to increase adoption of these technologies. The initiative will engage end-users and those interested in learning more about how these technologies can be used to promote the 3Rs.

Objectives:

Click here to see draft working group scope.

Planned deliverables:

Who should join?

Anyone interested in collaborating to facilitate new development and speed adoption of translational digital biomarkers.

How can I join?

Submit a Working Group Application

If you would like to participate but the membership dues cause financial hardship, please contact us.

Membership Expectations

Working Group Leadership Contact Information

Szczepan Baran     (617) 871-8255       szczpan.baran “at” novartis.com

Laura Schaevitz     (650) 797-2000 x118        laura “at” vium.com